No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr6:36203800-36220200 |
Weak transcription |
Right Atrium |
heart
|
2 |
chr6:36209200-36218200 |
Enhancers |
Fetal Intestine Small |
intestine
|
3 |
chr6:36211200-36218200 |
Enhancers |
Primary monocytes fromperipheralblood |
blood
|
4 |
chr6:36212200-36218200 |
Enhancers |
Fetal Intestine Large |
intestine
|
5 |
chr6:36212600-36217000 |
Enhancers |
Primary hematopoietic stem cells short term culture |
blood
|
6 |
chr6:36213200-36217000 |
Flanking Active TSS |
Monocytes-CD14+_RO01746 |
blood
|
7 |
chr6:36213600-36216800 |
Flanking Active TSS |
Primary neutrophils fromperipheralblood |
blood
|
8 |
chr6:36214600-36217600 |
Enhancers |
IMR90 fetal lung fibroblasts Cell Line |
lung
|
9 |
chr6:36214600-36217800 |
Enhancers |
HUVEC |
blood vessel
|
10 |
chr6:36214800-36217000 |
Enhancers |
Breast variant Human Mammary Epithelial Cells (vHMEC) |
Breast
|
11 |
chr6:36215000-36218200 |
Enhancers |
Mesenchymal Stem Cell Derived Adipocyte Cultured Cells |
ES cell derived
|
12 |
chr6:36215200-36217000 |
Enhancers |
Osteobl |
bone
|
13 |
chr6:36215200-36218000 |
Enhancers |
Muscle Satellite Cultured Cells |
--
|
14 |
chr6:36215200-36218000 |
Enhancers |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
15 |
chr6:36215200-36218200 |
Enhancers |
Foreskin Fibroblast Primary Cells skin02 |
Skin
|
16 |
chr6:36215400-36216800 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|
17 |
chr6:36215400-36217200 |
Enhancers |
HMEC |
breast
|
18 |
chr6:36215400-36217400 |
Enhancers |
NHEK |
skin
|
19 |
chr6:36215600-36217000 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin03 |
Skin
|
20 |
chr6:36215600-36217000 |
Enhancers |
Hela-S3 |
cervix
|
21 |
chr6:36215600-36220200 |
Enhancers |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
22 |
chr6:36215800-36217000 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
23 |
chr6:36215800-36217200 |
Weak transcription |
hESC Derived CD56+ Mesoderm Cultured Cells |
ES cell derived
|
24 |
chr6:36215800-36217200 |
Enhancers |
HepG2 |
liver
|
25 |
chr6:36215800-36217600 |
Enhancers |
NHDF-Ad |
bronchial
|
26 |
chr6:36216000-36220000 |
Weak transcription |
Sigmoid Colon |
Sigmoid Colon
|
27 |
chr6:36216200-36216800 |
Weak transcription |
Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells |
embryonic stem cell
|
28 |
chr6:36216200-36217000 |
Enhancers |
Fetal Adrenal Gland |
Adrenal Gland
|
29 |
chr6:36216200-36217600 |
Enhancers |
NHLF |
lung
|
30 |
chr6:36216400-36217000 |
Weak transcription |
NH-A |
brain
|
31 |
chr6:36216600-36216800 |
Enhancers |
H1 BMP4 Derived Trophoblast Cultured Cells |
ES cell derived
|
32 |
chr6:36216600-36216800 |
Enhancers |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
33 |
chr6:36216600-36216800 |
Enhancers |
Primary Natural Killer cells fromperipheralblood |
blood
|
34 |
chr6:36216600-36216800 |
Enhancers |
Fetal Muscle Trunk |
muscle
|
35 |
chr6:36216600-36216800 |
Enhancers |
Skeletal Muscle Female |
skeletal muscle
|
36 |
chr6:36216600-36217000 |
Enhancers |
Adipose Nuclei |
Adipose
|
37 |
chr6:36216600-36217000 |
Enhancers |
Aorta |
Aorta
|
38 |
chr6:36216600-36217000 |
Enhancers |
Ovary |
ovary
|
39 |
chr6:36216600-36217000 |
Enhancers |
Spleen |
Spleen
|